147 related articles for article (PubMed ID: 30611599)
1. Hemoptysis and Bronchiolitis Obliterans in Children with Recurrent Respiratory Papillomatosis: Adverse Reactions to Nebulized Cidofovir.
Sánchez-Moreno P; Falcón-Neyra L; Neth O; Delgado Pecellín I
Arch Bronconeumol (Engl Ed); 2019 Jul; 55(7):386-387. PubMed ID: 30611599
[No Abstract] [Full Text] [Related]
2. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
[TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
Tjon Pian Gi RE; Dietz A; Djukic V; Eckel HE; Friedrich G; Golusinski W; Hantzakos A; Lawson G; Remacle M; Rihkanen H; Dikkers FG
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):361-2. PubMed ID: 22020697
[No Abstract] [Full Text] [Related]
4. Immune Signature Variation in Twins With Clinically Different Recurrent Respiratory Papillomatosis.
Jayawardena ADL; Liu T; Pereira B; Wang Y; Baker L; Leary R; Mirambeaux M; Zablah E; Sabatos-Peyton CA; Hartnick CJ
Laryngoscope; 2021 Apr; 131(4):E1335-E1338. PubMed ID: 32722845
[No Abstract] [Full Text] [Related]
5. Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
Derkay CS; Volsky PG; Rosen CA; Pransky SM; McMurray JS; Chadha NK; Froehlich P
Laryngoscope; 2013 Mar; 123(3):705-12. PubMed ID: 23070868
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
[TBL] [Abstract][Full Text] [Related]
7. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Tjon Pian Gi RE; Ilmarinen T; van den Heuvel ER; Aaltonen LM; Andersen J; Brunings JW; Chirila M; Dietz A; Ferran Vilà F; Friedrich G; de Gier HH; Golusinski W; Graupp M; Hantzakos A; Horcasitas R; Jackowska J; Koelmel JC; Lawson G; Lindner F; Remacle M; Sittel C; Weichbold V; Wierzbicka M; Dikkers FG
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1679-87. PubMed ID: 23377227
[TBL] [Abstract][Full Text] [Related]
8. Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
Durvasula VS; Richter GT
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1912-5. PubMed ID: 24063771
[TBL] [Abstract][Full Text] [Related]
9. Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
Rivière F; Gille T; Le Tinier JY; Gharbi N; Khalil A; Wislez M; Cadranel J
Scand J Infect Dis; 2011 Feb; 43(2):112-4. PubMed ID: 21039305
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Safety of Intralesional Cidofovir for Adjuvant Treatment of Recurrent Respiratory Papillomatosis.
Hoesli RC; Thatcher AL; Hogikyan ND; Kupfer RA
JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):231-236. PubMed ID: 31895450
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis.
Avelino MA; Zaiden TC; Gomes RO
Braz J Otorhinolaryngol; 2013; 79(5):636-42. PubMed ID: 24141682
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of recurrent respiratory papillomatosis.
Wilcox LJ; Hull BP; Baldassari CM; Derkay CS
Pediatr Infect Dis J; 2014 Dec; 33(12):1283-4. PubMed ID: 25229272
[No Abstract] [Full Text] [Related]
13. Use of cidofovir in recurrent respiratory papillomatosis.
Carifi M
Eur Arch Otorhinolaryngol; 2013 Jul; 270(7):2165-6. PubMed ID: 23545883
[No Abstract] [Full Text] [Related]
14. Vocal cord surgery and pharmacological treatment of a patient with HPV and recurrent respiratory papillomatosis.
Galletti F; Freni F; Gazia F; Gallo A
BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31732543
[TBL] [Abstract][Full Text] [Related]
15. Letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Dikkers FG
Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1789. PubMed ID: 24012217
[No Abstract] [Full Text] [Related]
16. Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.
Graupp M; Gugatschka M; Kiesler K; Reckenzaun E; Hammer G; Friedrich G
Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):641-6. PubMed ID: 23070260
[TBL] [Abstract][Full Text] [Related]
17. Response to Dikkers letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Clamp PJ; Saunders MW
Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1789. PubMed ID: 24021212
[No Abstract] [Full Text] [Related]
18. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
20. Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis.
Ksiazek J; Prager JD; Sun GH; Wood RE; Arjmand EM
Otolaryngol Head Neck Surg; 2011 Apr; 144(4):639-41. PubMed ID: 21493248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
